Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1993]
News [3240]
Articles [134]
Editorials [3]
Conferences [122]
elearning [18]
Effective use of ibrutinib in the treatment of ABC lymphoma tumours
Dr Louis Staudt - National Cancer Institute, Bethesda, USA
Effective use of ibrutinib in the treatment of ABC lymphoma tumours ( Dr Louis Staudt - National Cancer Institute, Bethesda, USA )
1 May 2014
The 1st Immunotherapy of Cancer Conference (ITOC)
Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014
Reasons for combining immunotherapy with chemo to enhance anti tumour response
Prof Angus Dalgleish - St George's, University of London, London, UK
Reasons for combining immunotherapy with chemo to enhance anti tumour response ( Prof Angus Dalgleish - St George's, University of London, London, UK )
25 Mar 2014
High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated...
Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands
High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology ( Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands )
25 Mar 2014
Molecular pathways associated with immune modulation and thalidomide analogues
Dr Rajesh Chopra - Vice President of Translational and Early Drug Development...
Molecular pathways associated with immune modulation and thalidomide analogues ( Dr Rajesh Chopra - Vice President of Translational and Early Drug Development, Celgene )
25 Mar 2014
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma
Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios...
Multiple Myeloma Debate 2014: Recent advances in multiple myeloma ( Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos )
2 Feb 2014
Critical insights on leukaemia and lymphoma from ASH 2013
Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner
Critical insights on leukaemia and lymphoma from ASH 2013 ( Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner )
2 Feb 2014
Rituximab maintenance therapy and CLL treatment considerations going forward
Prof Ulrich Jäger - Medical University of Vienna, Austria
Rituximab maintenance therapy and CLL treatment considerations going forward ( Prof Ulrich Jäger - Medical University of Vienna, Austria )
1 Jan 2014
Trial results at ASH 2013
Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA
Trial results at ASH 2013 ( Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA )
1 Jan 2014
Oncotype DX: changing breast cancer treatment
Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project...
Oncotype DX: changing breast cancer treatment ( Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA )
19 Dec 2013
Meeting the needs of the elderly, unfit CLL patient
Prof Peter Hillmen - The Leeds Teaching Hospitals NHS Trust, Leeds, UK
Meeting the needs of the elderly, unfit CLL patient ( Prof Peter Hillmen - The Leeds Teaching Hospitals NHS Trust, Leeds, UK )
19 Dec 2013
Improving outcomes in chronic lymphocytic leukaemia
Prof John Gribben - Queen Mary University of London, UK and Prof Barbara...
Improving outcomes in chronic lymphocytic leukaemia ( Prof John Gribben - Queen Mary University of London, UK and Prof Barbara Eichhorst - University of Cologne, Germany )
19 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation